Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period.

Christine A Clark1, Karen A Spitzer, Carl A Laskin

  • 1Department of Medicine, University of Toronto, Ontario, Canada.

The Journal of Rheumatology
|September 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Rheumatology (Oxford, England)·2025
Same author

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.

Annals of the rheumatic diseases·2025
Same author

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

The Lancet. Rheumatology·2025
Same author

Long-Term Outcomes of Children Born to Anti-Ro Antibody-Positive Mothers With and Without Rheumatic Disease.

Arthritis care & research·2025
Same author

Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.

The Journal of rheumatology·2024

Pregnancy loss rates in systemic lupus erythematosus (SLE) pregnancies have significantly decreased over 40 years, now approximating general population rates. Preterm delivery rates show a decreasing trend, though still higher in SLE patients.

Area of Science:

  • Obstetrics and Gynecology
  • Rheumatology
  • Perinatal Medicine

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect pregnancy.
  • Historically, SLE pregnancies were associated with high rates of adverse outcomes.
  • Recent advancements in disease management and monitoring may have improved outcomes.

Purpose of the Study:

  • To evaluate changes in pregnancy loss and preterm delivery rates in patients with SLE over time.
  • To compare SLE pregnancy outcomes with general population norms.
  • To assess the impact of improved medical care on SLE pregnancy outcomes.

Main Methods:

  • Analysis of pregnancy outcomes in SLE patients over 3 years.
  • Literature review of SLE pregnancy outcomes over 40 years.

Related Experiment Videos

  • Statistical analysis including linear regression and comparison with population norms.

    • Main Results:

    • Pregnancy loss in SLE decreased from 43% (1960-1965) to 17% (2000-2003), aligning with general population rates.
    • A trend towards decreased preterm births in SLE pregnancies was observed from 1980-2002.
    • Preterm delivery rates remain higher in SLE pregnancies compared to the general population.

    Conclusions:

    • Improved SLE disease management and perinatal care have significantly reduced pregnancy loss.
    • There is a positive trend in reducing preterm deliveries in SLE pregnancies.
    • Enhanced collaboration between rheumatologists and perinatologists is crucial for optimizing outcomes.